These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2696675)

  • 1. Immunologic subclassification of acute lymphoblastic leukemia in childhood and prognosis (modified BFM protocol).
    Zintl F; Häfer R
    Haematol Blood Transfus; 1989; 32():109-12. PubMed ID: 2696675
    [No Abstract]   [Full Text] [Related]  

  • 2. Incidence and prognostic significance of immunophenotypic subgroups in childhood acute lymphoblastic leukemia: experience of the BFM study 86.
    Ludwig WD; Harbott J; Bartram CR; Komischke B; Sperling C; Teichmann JV; Seibt-Jung H; Notter M; Odenwald E; Nehmer A
    Recent Results Cancer Res; 1993; 131():269-82. PubMed ID: 8210646
    [No Abstract]   [Full Text] [Related]  

  • 3. [Incidence, clinical markers and prognostic significance of immunologic subtypes of acute lymphoblastic leukemia (ALL) in children: experiences of the ALL-BFM 83 and 86 studies].
    Ludwig WD; Teichmann JV; Sperling C; Komischke B; Ritter J; Reiter A; Odenwald E; Sauter S; Riehm H
    Klin Padiatr; 1990; 202(4):243-52. PubMed ID: 2203938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological features and prognostic implications of immunophenotypic subgroups in childhood ALL: experience of the BFM-ALL Study 83.
    Ludwig WD; Seibt-Jung H; Teichmann JV; Komischke B; Gatzke A; Gassner G; Odenwald E; Hofmann J; Riehm H
    Haematol Blood Transfus; 1989; 32():51-7. PubMed ID: 2696693
    [No Abstract]   [Full Text] [Related]  

  • 5. Results of acute lymphoblastic leukemia therapy in childhood: GDR-experiences 1981-1987.
    Zintl F; Malke H; Reimann M; Dörffel W; Domula M; Eggers G; Exadaktylos P; Kotte W; Krause I; Kunert W
    Haematol Blood Transfus; 1990; 33():478-82. PubMed ID: 2182440
    [No Abstract]   [Full Text] [Related]  

  • 6. [Progress in the treatment of acute lymphoid leukemia in children. Experience of the GATLA/GLATHEM, 1967-1987].
    Garay G; Aversa LA; Svarch E; Sackmann Muriel F; Drelichman G; Santarelli MT; Jiménez E; Divito JM; Pavlovsky S; Eppinger Helft M
    Sangre (Barc); 1989 Apr; 34(2):136-43. PubMed ID: 2667171
    [No Abstract]   [Full Text] [Related]  

  • 7. DNA aneuploidy in childhood acute lymphoblastic leukemia: relation to clinical determinants and prognosis within four consecutive BFM trials.
    Hiddemann W; Harbott J; Ludwig WD; Ritter J; Nehmer A; Reiter A; Kolkmeyer A; Laing T; Riehm H
    Recent Results Cancer Res; 1993; 131():113-21. PubMed ID: 8210632
    [No Abstract]   [Full Text] [Related]  

  • 8. Biology and therapy of childhood acute lymphoblastic leukemia.
    Rivera GK; Crist WM; Sallan SE
    Rev Invest Clin; 1994 Apr; Suppl():26-33. PubMed ID: 7886304
    [No Abstract]   [Full Text] [Related]  

  • 9. BFM group treatment results in relapsed childhood acute lymphoblastic leukemia.
    Henze G; Fengler R; Hartmann R; Niethammer D; Schellong G; Riehm H
    Haematol Blood Transfus; 1990; 33():619-26. PubMed ID: 2182452
    [No Abstract]   [Full Text] [Related]  

  • 10. Dutch Childhood Leukemia Study Group: early results of study ALL VI (1984-1988).
    Veerman AJ; Hählen K; Kamps WA; Vanleeuwen EF; de Vaan GA; Vanwering ER; Vanderdoes-Vandenberg A; Solbu G; Suciu S
    Haematol Blood Transfus; 1990; 33():473-7. PubMed ID: 2182439
    [No Abstract]   [Full Text] [Related]  

  • 11. Precursor B-cell lymphoblastic lymphoma in childhood and adolescence: clinical features, treatment, and results in trials NHL-BFM 86 and 90.
    Neth O; Seidemann K; Jansen P; Mann G; Tiemann M; Ludwig WD; Riehm H; Reiter A
    Med Pediatr Oncol; 2000 Jul; 35(1):20-7. PubMed ID: 10881003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of acute lymphoblastic leukemia: protocol Fralle 83-85.
    Schaison G; Olive D; Leverger G; Vannier JP; de Lumley L; Bancillon A; Cornu G
    Haematol Blood Transfus; 1990; 33():467-72. PubMed ID: 2182438
    [No Abstract]   [Full Text] [Related]  

  • 13. Minimal residual disease-based augmented therapy in childhood acute lymphoblastic leukemia: a report from the Japanese Childhood Cancer and Leukemia Study Group.
    Yamaji K; Okamoto T; Yokota S; Watanabe A; Horikoshi Y; Asami K; Kikuta A; Hyakuna N; Saikawa Y; Ueyama J; Watanabe T; Okada M; Taga T; Kanegane H; Kogawa K; Chin M; Iwai A; Matsushita T; Shimomura Y; Hori T; Tsurusawa M;
    Pediatr Blood Cancer; 2010 Dec; 55(7):1287-95. PubMed ID: 20535816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment results of childhood acute lymphoblastic leukemia in Austria--a report of 20 years' experience.
    Attarbaschi A; Mann G; Dworzak M; Urban C; Fink FM; Dieckmann K; Riehm H; Gadner H;
    Wien Klin Wochenschr; 2002 Feb; 114(4):148-57. PubMed ID: 12060981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutic strategies for childhood high-risk acute lymphoblastic leukemia].
    Lu XT
    Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 45(2):327-32. PubMed ID: 23591360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical utility of miR-143/miR-182 levels in prognosis and risk stratification specificity of BFM-treated childhood acute lymphoblastic leukemia.
    Piatopoulou D; Avgeris M; Drakaki I; Marmarinos A; Xagorari M; Baka M; Pourtsidis A; Kossiva L; Gourgiotis D; Scorilas A
    Ann Hematol; 2018 Jul; 97(7):1169-1182. PubMed ID: 29556721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of cytogenetic studies in childhood acute lymphoblastic leukemia: experience of the BFM trials.
    Harbott J; Ritterbach J; Ludwig WD; Bartram CR; Reiter A; Lampert F
    Recent Results Cancer Res; 1993; 131():123-32. PubMed ID: 8210633
    [No Abstract]   [Full Text] [Related]  

  • 18. [Outcome of childhood high-risk acute lymphoblastic leukemia treated with the ALL-BFM 95 protocol].
    Ruan YS; Wu XD; Feng XQ; He YL; Zhang YM; Pei FY; Li CF
    Zhongguo Dang Dai Er Ke Za Zhi; 2015 Apr; 17(4):327-31. PubMed ID: 25919549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experiences with modified BFM protocols in the treatment of children with acute lymphoblastic leukemia (ALL) in East Germany 1981-1991].
    Zintl F; Malke H; Reimann M; Hermann J; Domula M; Dörffel W; Eggers G; Exadaktylos P; Hilgenfeld E; Kotte W
    Klin Padiatr; 1992; 204(4):221-9. PubMed ID: 1518257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensive chemotherapy for childhood acute lymphoblastic leukemia: results of the randomized intercontinental trial ALL IC-BFM 2002.
    Stary J; Zimmermann M; Campbell M; Castillo L; Dibar E; Donska S; Gonzalez A; Izraeli S; Janic D; Jazbec J; Konja J; Kaiserova E; Kowalczyk J; Kovacs G; Li CK; Magyarosy E; Popa A; Stark B; Jabali Y; Trka J; Hrusak O; Riehm H; Masera G; Schrappe M
    J Clin Oncol; 2014 Jan; 32(3):174-84. PubMed ID: 24344215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.